The user will also have access to an exclusive area with information about Cannabidiol. Photo:Prati-Donaduzzi
Prati-Donaduzzi Pharmaceutical Industry announces a new stage of its trajectory in the area of Medical Prescriptions. The pharmaceutical company from Paraná has just launched a website, which in addition to benefiting the population with health information, will have an exclusive area for physicians, with scientific and entertainment issues.
“The website will allow the physician to have access to free, quality and interest content at the time he prefers. In addition to scientific topics, we will also provide diversified content. We understand that due to the work routine, these professionals are often restricted to participate in certain events, especially those that take place during business hours, so we are proposing something innovative in the market”, explains Edilson Bianqui, Director of Medical Prescription at Prati-Donaduzzi.
When accessing the website, in the restricted area for physicians, the healthcare professional will find information about several pathologies, clinical cases written by colleagues from various specialties, scientific articles, virtual symposia and, of course, the portfolio of branded products from Prati- Donaduzzi.
The user will also have access to an exclusive area with information about Cannabidiol, with quality scientific materials, news and medical classes with renowned opinion makers so that doctors who still have doubts about the prescription of Cannabidiol can feel safer to indicate and prescribe the product.
In addition to the scientific issues, the pharmaceutical company will make available in its new hotsite courses in other areas focused on the sector, such as personal finance, medical marketing and office management. They will also have entertainment content such as oenology, visagism, cuisine, among others. "The aim is to assist the physician in his/her personal demands, in addition to strengthening the relationship with the industry", says the director.
In the coming years, Prati-Donaduzzi foresees a great growth in the area of Medical Prescriptions. According to Bianqui, the company shall focus its efforts on incremental innovations, that is, it will improve existing products. “Bringing innovative products to the market is the focus of Prati-Donaduzzi”, says the director, who added that more launches are planned until next year. There will be 22 new products, most aimed at the Central Nervous System (CNS) and indicated for the treatment of diseases such as epilepsy, Parkinson's, Alzheimer's, anxiety, depression, neuropathic pain, schizophrenia, autism, bipolar and insomnia.
Visit Prati-Donaduzzi hotsite through the following link:
Prati-Donaduzzi, a Brazilian pharmaceutical industry, is specialized and a benchmark in the development and production of generic drugs. Headquartered in Toledo, Western Paraná, it produces approximately 12 billion therapeutic doses per year and generates more than 4,600 employments. The industry has one of the largest generic drug portfolios in Brazil and it has been working in the area of Medical Prescriptions since 2019.
*IQVIA MAT SET/2020 PMB + NRC Doses Terapêuticas
Rodrigo Freitas | Maira Manesco
Telefone: +55 (11) 96351-5239